Gordian Biotechnology
PrivateLast Round
Series A
Dec 31, 2021
Est. Valuation
$170M
Total Funding Raised
$61.96M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Gordian Biotechnology is a biotechnology company that has developed an in vivo gene therapy discovery platform aimed at identifying and validating therapeutic targets for complex age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gordian Biotechnology Comparables
Compare Gordian Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tahoe Therapeutics | 81% | |
| Manifold Bio | 79% | |
| Octant | 74% |
Gordian Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 31, 2021 | ||||
| Grant | Feb 1, 2021 | ||||
| Accelerator | Mar 16, 2020 |
Gordian Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A |
| NIH RADx | Grant |
| Founders Fund | Series A |
| GigaFund | Series A |
| Y Combinator | Accelerator |
| The Longevity Fund | Series A |
| National Institute of Environmental Health Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 172% MoM, reaching 18K.
- Aug 21, 2026
Monthly visitors increased 58% MoM.
Gordian Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gordian Biotechnology's valuation, stock price, and market status.
Is Gordian Biotechnology a public or private company?
Gordian Biotechnology is a private company.
What is the current stock price of Gordian Biotechnology?
Gordian Biotechnology is a private company, so its shares have no public market price. Caplight tracks Gordian Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gordian Biotechnology worth (valuation)?
Gordian Biotechnology's valuation is estimated at $170.0M based on funding round data.
Can I buy Gordian Biotechnology stock?
Gordian Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gordian Biotechnology's last funding round?
Gordian Biotechnology's most recent funding round was Series A on December 31, 2021.
Who are the main investors in Gordian Biotechnology?
Key investors in Gordian Biotechnology include Horizons Ventures, NIH RADx, Founders Fund, GigaFund, Y Combinator.
Will Gordian Biotechnology IPO soon?
No public IPO plans have been announced for Gordian Biotechnology.
How can I track Gordian Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Gordian Biotechnology's shares on secondary markets.